All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • IBD0333Phase 21 trial

    SUNHO(China)BioPharmaceutical CO., Ltd. · MTD

  • IbezapolstatACX-362EPhase 21 trial

    Acurx Pharmaceuticals Inc. · Clostridium Difficile Infection Recurrence

  • IBI129Phase 21 trial

    Innovent Biologics (Suzhou) Co. Ltd. · Solid Tumor

  • IBI133Phase 21 trial

    Innovent Biologics (Suzhou) Co. Ltd. · Locally Advanced Unresectable or Metastatic Solid Tumors

  • IBI3002Phase 21 trial

    Innovent Biologics (Suzhou) Co. Ltd. · Atopic Dermatitis

  • IBI3005Phase 21 trial

    Innovent Biologics (Suzhou) Co. Ltd. · Solid Tumor

  • IBI3014Phase 21 trial

    Innovent Biologics (Suzhou) Co. Ltd. · Unresectable Locally Advanced or Metastatic Solid Tumors

  • IBI3016Phase 21 trial

    Innovent Biologics (Suzhou) Co. Ltd. · Hypertension

  • IBI305Phase 21 trial

    Innovent Biologics (Suzhou) Co. Ltd. · EGFR Mutant NSCLC and Platinum Resistant Ovarian Cancer

  • IBI334Phase 21 trial

    Innovent Biologics (Suzhou) Co. Ltd. · Advanced Solid Tumors

  • IBI355Phase 21 trial

    Innovent Biologics (Suzhou) Co. Ltd. · Sjögren's Disease

  • IBR854Phase 21 trial

    Imbioray (Hangzhou) Biomedicine Co., Ltd. · Renal Cell Carcinoma (RCC)

  • ICP-192Phase 21 trial

    Beijing InnoCare Pharma Tech Co., Ltd. · Intrahepatic Cholangiocarcinoma (ICC)

  • ICP-322Phase 21 trial

    Beijing InnoCare Pharma Tech Co., Ltd. · Prurigo Nodularis (PN)

  • ICP-490Phase 21 trial

    Beijing InnoCare Pharma Tech Co., Ltd. · Relapsed or Refractory Non-Hodgkin Lymphoma

  • ICT01Phase 21 trial

    ImCheck Therapeutics, an Ipsen company · Solid Tumor, Adult, Hematopoietic/Lymphoid Cancer

  • IDE161Phase 21 trial

    IDEAYA Biosciences · Small-cell Lung Cancer, Neuroendocrine Carcinomas, Solid Tumor Show to Express DLL3

  • IDE397Phase 21 trial

    Amgen · MTAP-null Non-Small-Cell Lung Cancer, MTAP-null Solid Tumors

  • IDE849Phase 21 trial

    IDEAYA Biosciences · Small-cell Lung Cancer, Neuroendocrine Carcinomas, Solid Tumor Show to Express DLL3

  • IDP-001Phase 21 trial

    InduPro, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Head and Neck Squamous Cell Carcinoma

  • IDP-023Phase 21 trial

    Indapta Therapeutics, INC. · NHL, Multiple Myeloma, Blood Cancer

  • IDX-1197Phase 21 trial

    Idience Co., Ltd. · Gastric Cancer

  • IG3018Phase 21 trial

    Intelligem Therapeutics Australia Pty Ltd. · Hyperuricemia, Hypouricemia, Renal

  • IGT-303Phase 21 trial

    Ingenia Therapeutics INC · Healthy Volunteers, Chronic Kidney Disease

  • ILKN421HPhase 21 trial

    iLeukon Therapeutics, Inc. · Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

  • IlofotasePhase 21 trial

    AM-Pharma · Open Heart Surgery

  • IMA401Phase 21 trial

    Immatics Biotechnologies GmbH · Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult

  • IMA402Phase 21 trial

    Immatics Biotechnologies GmbH · Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult

  • IMGN151Phase 21 trial

    AbbVie · Gynecologic Cancers, Platinum-Sensitive Ovarian Cancer, Fallopian Tube Cancer

  • IMNN-101Phase 21 trial

    Imunon · SARS CoV 2 Infection

  • ImofinostatABT-301, MPT0E028Phase 21 trial

    Anbogen Therapeutics, Inc. · Colorectal Cancer (Diagnosis), Colorectal Cancer Metastatic, Colorectal Cancer (CRC)

  • IMP 08P2002F0Phase 21 trial

    Unither Pharmaceuticals, France · Mydriasis

  • IMP1734Phase 21 trial

    Eikon Therapeutics · Advanced Solid Tumor

  • IMP9064Phase 21 trial

    Impact Therapeutics, Inc. · Solid Tumor, Advanced Solid Tumor

  • IMT-009Phase 21 trial

    Immunitas Therapeutics · Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Triple Negative Breast Cancer

  • IN-207907Phase 21 trial

    HK inno.N Corporation · Sarcopenia in Elderly

  • INB301Phase 21 trial

    Yunnan Baiyao Group Co., Ltd. · Cancer Cachexia

  • INBRX-109Phase 21 trial

    Inhibrx Biosciences, Inc · Conventional Chondrosarcoma

  • INCA000585Phase 21 trial

    Incyte · Immune Thrombocytopenia

  • INDV-2000Phase 21 trial

    Indivior Inc. · Opioid Use Disorder

  • INDV-6001Phase 21 trial

    Indivior Inc. · Moderate to Severe Opioid Use Disorder

  • INI-2004Phase 21 trial

    Inimmune Corporation · Allergic Rhinitis Due to Allergens, Rhinitis Allergic, Allergic Rhinitis

  • INN imapextideMBX 1416Phase 21 trial

    MBX Biosciences · Postbariatric Hypoglycemia

  • INNA-051Phase 21 trial

    ENA Respiratory Pty Ltd · Viral Respiratory Infection, Viral Respiratory Illnesses

  • INP20Phase 21 trial

    InnoUp Farma S.L. · Peanut Allergy

  • INT-210Phase 21 trial

    Innatus Therapeutics (Shanghai) Co., Ltd. · Ulcerative Colitis (UC)

  • intraocular implant releasing timololTimoD implantPhase 21 trial

    EyeD Pharma · Glaucoma, Ocular Hypertension

  • INV-102Phase 21 trial

    Invirsa, Inc. · Non-center Involved Diabetic Macular Edema, Non-center Involved Diabetic Macular Edema Associated With Non-proliferative Diabetic Retinopathy, Diabetic Retinopathy

  • INV-6452Phase 21 trial

    Shenzhen Ionova Life Sciences Co., Ltd. · Breast Cancer (Locally Advanced or Metastatic), Advanced Solid Cancers, Metastatic (Stage IV) Breast Cancer

  • INV-8989Phase 21 trial

    Shenzhen Ionova Life Sciences Co., Ltd. · Advance Solid Tumors, Colon and Rectal Cancer, Non - Small Cell Lung Cancer NSCLC

NewerPage 57 of 74Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.